There may be exciting news on the horizon for those who suffer from asthma. A new experimental drug is showing promise in clinical trials as a potential way to treat asthma in those who have been resistant to other forms of treatment. Researchers state that between 10 and 20% of patients are not able to fully control their asthma symptoms using traditional therapies, and the scientists hope that their new drug will help this subset of sufferers. Rather than treating the symptoms of asthma, as many other medications do, the drug has been designed to treat the underlying cause of asthma. So far, their results have been quite promising. After a 12 week trial, patients using the new drug were found to have an 87% reduction in asthma attacks. As of right now, more research and testing will be required before the drug will become available.
Over 25 million Americans are thought to suffer from asthma, a chronic respiratory disease where airways in the lungs become inflamed and restricted, causing shortness of breath and trouble breathing. These symptoms can be worsened by exposure to environmental triggers, such as allergens and air pollutants, as well as factors such as diet, illness or vigorous physical activity. Traditional treatments include administration of steroids or use of inhalers to control symptoms as they occur. Managing exposure to environmental triggers can also prove helpful in reducing asthma attacks. At home, sufferers can use an air purifier with a true HEPA filter, like our MinusA2 Asthma and Allergy Friendly Edition, to filter the air of dust, pollen, and pollutants that can trigger an attack. It is also helpful to remove items that tend to collect lots of dust, such as curtains or carpets. For more ideas about how to control asthma and information on the latest research, visit the Asthma and Allergy Foundation of America’s website.